Table 17:
Sensitivity Analysis—MRgHIFU Funded at Two Currently Existing Centres (Replacing a Proportion of All Procedures)
| Parameter | Base Case Value | Sensitivity Analysis Value | Current Expenditure | Expenditure With MRgHIFU Funded | Budget Impact (Compared With Current Expenditure) |
|---|---|---|---|---|---|
| Base case results | $35,491,984 | $34,107,509 | ($1,138,475) | ||
| Peri-procedure direct/indirect costs of myomectomy | $5,094 | ||||
| $6,000a | $37,011,256 | $35,442,866 | ($1,568,390) | ||
| $6,500 | $37,849,706 | $36,179,818 | ($1,669,888) | ||
| $7,400 | $39,358,916 | $37,506,331 | ($1,852,585) | ||
| $8,400 | $41,035,816 | $38,980,234 | ($2,055,581) | ||
| Peri-procedure cost of MRgHIFU | $3,499 | ||||
| −15% | $35,491,984 | $33,780,041 | ($1,711,943) | ||
| +15% | $35,491,984 | $34,434,977 | ($1,057,007) | ||
| +50%b | $35,491,984 | $35,199,069 | ($292,915) | ||
| Number of MRgHIFU procedures per week | 6 | ||||
| 3 | $35,491,984 | $35,499,747 | $7,763 | ||
| 4 | $35,491,984 | $35,035,667 | ($456,317) | ||
| 5 | $35,491,984 | $34,571,588 | ($920,396) | ||
| 8 | $35,491,984 | $33,179,351 | ($2,312,633) | ||
| 10 | $35,491,984 | $32,251,192 | ($3,240,792) | ||
| Number of additional centres with MRgHIFU | 0 | ||||
| 1 | $35,491,984 | $33,415,272 | ($2,076,712) | ||
| 2 | $35,491,984 | $32,723,034 | ($2,768,950) | ||
| 3 | $35,491,984 | $32,030,797 | ($3,461,187) | ||
| 4 | $35,491,984 | $31,489,431 | ($4,002,553) |
Abbreviation: MRgHIFU, magnetic resonance-guided high-intensity focused ultrasound.
a
Maximum costs for myomectomy as captured through OCCI (codes 1RM87CAGX, 1RM87BAGX, 1RM87DAAG, and 1RM87LAAK), details in Appendix 2, Table A8.
b
This value chosen to demonstrate the break-even point in terms of direct costs for MRgHIFU.